NEW YORK, Jan. 28, 2014 /PRNewswire/ -- The Galien Foundation applauds today's announcement by Sanford-Burnham Medical Research Institute (Sanford-Burnham) that the Institute has received an anonymous philanthropic pledge of $275 million to help fund the strategic initiatives of the organization's new 10-year vision focused on biomedical research, translational research, and drug discovery and development.
"This gift, coupled with Sanford-Burnham's strategic focus to help pioneer the next wave of biomedical discoveries, underscores the importance of private and non-profit organizations coming together to advance innovation for our industry, especially as we see government funding and resources for fundamental and translational biomedical research shrinking," said Bruno Cohen, Chairman of the Galien Foundation. "We applaud the benefactor and Sanford-Burnham for their commitment to advancing biomedical science and innovation, and for their focus on improving patient lives and human health."
About the Galien Foundation
The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatment and technologies that will impact human health and save lives.
The Foundation oversees and directs activities in the USA for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative therapies. The Prix Galien was created in 1970 in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.
For more information visit www.galienfoundation.org.
Galien Foundation Media Contact:
SOURCE Galien Foundation